Characterization of glycopeptides, aminoglycosides and macrolide resistance among Enterococcus faecalis and Enterococcus faecium isolates from hospitals in Tehran

• Autorzy: Emaneini M , Aligholi M. , Aminshahi M.
• Języki publikacji: EN

Abstrakty

EN

The prevalence of glycopeptides, aminoglycosides and erythromycin resistance among Enterococcus faecalis and Enterococcus faecium was investigated. The susceptibility of 326 enterococcal hospital isolates to amikacin, kanamycin, netilmicin and tobramycin were determined using disk diffusion method. The minimum inhibitory concentration (MIC) of vancomycin, teicoplanin, gentamicin, streptomycin, and erythromycin were determined by microbroth dilution method. The genes encoding aminoglycoside modifying enzymes described as AMEs genes, erythromycin-resistant methylase (erm) and vancomycin-resistant were targeted by multiplex-PCR reaction. High level resistance (HLR) to gentamicin and streptomycin among enterococci isolates were 52% and 72% respectively. The most prevalent of AMEs genes were aac (6')-Ie aph (2") (63%) followed by aph (3') -IIIa (37%). The erythromycin resistance was 45% and 41% of isolates were positive for ermB gene. The ermA gene was found in 5% of isolates whereas the ermC gene was not detected in any isolates. The prevalence of vancomycin resistant enterococci (VRE) was 12% consisting of E. faecalis (6%) and E. faecium (22%) and all of them were VanA Phenotype. The results demonstrated that AMEs, erm and van genes are common in enterococci isolated in Tehran. Furthermore our results show an increase in the rate of vancomycin resistance among enterococci isolates in Iran.

Słowa kluczowe

EN

ermB gene; ermA gene; erythromycin; detection; Tehran; ermC gene; macrolide; Enterococcus faecalis; vancomycin resistance; strain isolate; Enterococcus faecium; glycopeptide; hospital; aminoglycoside

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2008
• Tom: 57
• Numer: 2
• Opis fizyczny: p.173-178,ref.

Twórcy

autor

Emaneini M

• University of Tehran, 100 Poursina St., Keshavarz Blvd., Tehran, Iran

autor

Aligholi M.

autor

Aminshahi M.

Bibliografia

• Cetinkaya Y., P. Falk and C.G. Mayhall. 2000. Vancomycin-Resistant Enterococci. J. Clin. Microbiol. Rev. 13: 680-707.
• Chow J.W, V. Kak, I. You, S.J. Kao, J. Petrin, D.B. Clewell, S.A. Lerner, G.H. Miller and K.J. Shaw.2001. Aminoglycoside resistance genes aph (2”)-Ib and aac(6')-Im detected together in strains of both Escherichia coli and Enterococcus faecium. Antimicrob. Agents. Chemother. 45: 2691-2694.
• del Campo R., C. Tenorio, C. Rubio, J. Castillo, C. Torres and R. Go'mez-Lus. 2000. Aminoglycoside-modifying enzymes in high-level streptomycin and gentamicin resistant Enterococcus spp. in Spain. Int. J. Antimicrob. Agents 15: 221-226.
• De Leener E., A. Martel, A. Decostere and F. Haesebrouck. 2004. Distribution of the erm(B) gene, tetracycline resistance genes, and Tn1545-like transposons in macrolide- and lincosamide-resistant enterococci from pigs and humans. Microb Drug Resist. 10: 341-345.
• Dutka-Malen S., S. Evers and P. Courvalin.1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33: 24-27.
• Emaneini M., F.B. Hashemi, M. Aligholi, B. Fatholahzadeh, B. Kazemi and F. Sadeghi. 2005. Detection of vanB genotype enterococci in Iran. Int. J. Antimicrob. Agents. 26:98-9.
• Facklam R.R, and M.D. Collins. 1989. Identification of enterococcus species isolated from human infection by a conventional test scheme. J. Clin. Microbiol. 27: 731-734.
• Feizabadi M.M., P. Maleknejad, A. Asgharzadeh, S. Asadi, L. Shokrzadch and S. Sayadi. 2006. Prevalence of aminoglycoside-modifying enzymes genes among isolates of Enterococcus faecalis and Enterococcus faecium in Iran. Microb. Drug. Resist. 12: 265-268.
• Feizabadi M.M., S. Asadi, A. Aliahmadi, M. Parvin, R. Parastan, M. Shayegh and G. Etemadi. 2004. Drug resistant patterns of enterococci recovered from patients in Tehran during 2000-2003. Int. J. Antimicrob. Agents 24: 521-522.
• Forbes B. A., D.F. Sahm and A. Weisfcld. 1998. Catalase Negative Cram Positive Cocci. Baily and Scott s Diagnostic Microbiology. 10th Ed. St. Louis, Missouri. USA; Mosby Inc; P: pp. 620-635.
• Gordon S., J.M. Swenson, B.C. Hill, N.E. Pigott, R.R. Facklam, R.C. Cooksey, C. Thornsberry, W.R. Jarvis and F.C. Tenover. 1992. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal study group. J. Clin. Microbiol. 30: 2373-2378.
• Kaçmaz B. and A. Aksoy. 2005. Antimicrobial resistance of enterococci in Turkey. Int. J. Antimicrob. Agents 25: 535-538.
• Kholy A., H. Baseem, G.S. Hall, G.W. Procop and D.L. Longworth. 2003. Antimicrobial resistance in Cairo, Egypt 1999-2000: a survey of five hospitals. J. Antimicrob. Chemother. 51: 625-630.
• Lim J.A., A.R. Kwon, S.K. Kim, Y. Chong, K. Lee, and E.C. Choi. 2002. Prevalence of resistance to macrolide, lincosamide and streptogramin antibiotics in Gram-positive cocci isolated in a Korean hospital. J. Antimicrob. Chemother. 49: 489-95.
• Martineau F., F.J. Picard and N. Lansac. 2000. Correlation between the resistance genotype determined by Multiplex-PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents. Chemother. 44: 231-238.
• National Committee for Clinical Laboratory Standards. 2004. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A4. NCCLS, Wayne, PA, USA.
• Portillo A., F. Ruiz-Larrea, M. Zarazaga, A. Alonso, J.L. Martinez and C. Torres. 2000. Macrolide resistance genes in Enterococcus spp. Antimicrob. Agents. Chemother. 44: 967-971.
• Reyes J., M. Hidalgo, L. Díaz, S. Rincón, J. Moreno, N. Vanegas, E. Castańeda and C.A. Arias. 2007. Characterization of macrolide resistance in Gram-positive cocci from Colombian hospitals: a countrywide surveillance. Int. J. Infect. Dis. 11: 329-336.
• Schmitz F.J., R. Sadurski, A. Kray, M. Boos, R. Geisel, K. Köhrer, K. Köhrer, J. Verhoef and A.C. Fluit. 2000. Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J. Antimicrob. Chemother. 45: 891-894
• Shaw K.J., P.N. Rather, R.S. Hare and G.H. Miller. 1993. Molecular genetics of aminoglycoside resistance genes and familial relationships of aminoglycoside-modifying enzymes. Microbiol. Rev. 57: 138-163.
• Strommenger B., C. Kettlitz, G. Werner and W. Witte. 2003. Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus. J. Clin. Microbiol. 41: 4089-4094.
• Takeuchi K., H. Tomita, S. Fujimoto, M. Kudo, H. Kuwano and Y. Ike. 2005. Drug resistance of Enterococcus faecium clinical isolates and the conjugative transfer of gentamicin and erythromycin resistance traits. FEMS. Microbiol. Lett. 243: 347-54.
• Udo E.E., N. Al-Sweih, and T.D. Chugh. 2002. Antibiotic resistance of Enterococci isolated at a teaching hospital in Kuwait. Diagn. Microbiol. Infect. Dis. 43: 233-238.
• Udo E.E., N. Al-Sweih, P. John, L.E. Jacob and S. Mohanakrishnan. 2004. Characterization of high-level aminoglycoside-resistant enterococci in Kuwait Hospitals. Microb. Drug. Resist. 10: 139-145.
• Vakulenko S.B., S.M. Donabedian, A.M. Voskresenskiy, M.J. Zervos, S.A. Lerner and J.W. Chow. 2003. Multiplex PCR for detection of aminoglycoside resistance genes in enterococci. Antimicrob. Agents. Chemother. 47: 1423-1426.
• Witte W., R. Wirth and I. Klare. 1999. Enterococci. Chemotherapy 45: 135-145.
• Zarrilli R., M.F. Tripodi, A. Di Popolo, R. Fortunato, M. Bagattini, M. Crispino, A. Florio, M. Triassi and R. Utili. 2005. Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy. J. Antimicrob. Chemother. 56: 827-835.
• Zouain M.G. and G.F. Araj. 2001. Antimicrobial resistance of Enterococci in Lebanon. Int. J. Antimicrob. Agents 17: 209-213.